• Mashup Score: 4
    Navigating the Frontier of Hematologic Malignancy Therapies - 1 year(s) ago

    This activity will cover the latest advances in the therapeutic management of hematologic malignancies, including bispecific antibodies, CAR-T products, proteolysis-targeting chimeras, and antibody-drug conjugates — with an emphasis on novel targets and approaches. The prognostic role of…

    Source: freeCME.com
    Categories: Hem/Onc News and Journals, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of LLSResearch
      LLSResearch

      Did you miss our #ASH22 Symposium "Navigating the Frontier of Hematologic Malignancy Therapies"? Hear from experts & earn CME credits: @szusmani, @RoschewskiMD and Drs. Katherine Donovan @DanaFarber, Soheil Meshinchi @fredhutch & Helen Heslop @bcmhouston 👉https://t.co/WJ6EkN8tDv https://t.co/PBfcDy0Czp